Aaron Chang holds extensive experience in product development and leadership within the healthcare sector. Currently serving as the Director of Product Development at KeraLink International since June 2023, Aaron Chang focuses on innovative technologies to combat corneal blindness. As CEO of Renalert, a position held since February 2016, Aaron Chang aims to reduce mortality associated with Acute Kidney Injury. Additional roles include Associate at the Alliance for Artificial Intelligence in Healthcare since 2019, Strategy and Technical Advisor at R2H Action until December 2023, and former Director of Product at Dascena. Educational credentials include an MBA from Duke University, a Master’s in Bioengineering Innovation and Design from The Johns Hopkins University, and a Bachelor’s in Biomedical Engineering from the same institution.
Org chart
Sign up to view 0 direct reports
Get started